CN103550480A - Chinese herbal preparation for treating coronary heart disease complicated with hypertension - Google Patents
Chinese herbal preparation for treating coronary heart disease complicated with hypertension Download PDFInfo
- Publication number
- CN103550480A CN103550480A CN201310567272.5A CN201310567272A CN103550480A CN 103550480 A CN103550480 A CN 103550480A CN 201310567272 A CN201310567272 A CN 201310567272A CN 103550480 A CN103550480 A CN 103550480A
- Authority
- CN
- China
- Prior art keywords
- radix
- parts
- coronary heart
- chinese medicine
- heart disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a Chinese herbal preparation for treating coronary heart disease complicated with hypertension. In modern medicine, most of the coronary heart diseases belong to thoracic obstruction domain of the traditional Chinese medicine. According to the traditional Chinese medicine differentiation, the patient of coronary heart disease complicated with hypertension has common symptoms of yin deficiency, yang excess, blood stasis and obstruction, and the pathogenesis lies in deficiency in origin and enrichment in symptom. The Chinese herbal preparation disclosed by the invention is a decoction prepared by decocting traditional Chinese medicines such as foldleaf daylily root, caragana microphylla, Chinese holly bark, the root of cynanchum inamoenum, bornet cowlily rhizome, the root of dalbergia hupeana, prunus japonica, black mountain ebony, love-lies-bleeding root, daphne odera, hairy clover shrub and ventilago leiocarpa benth which have the effects of nourishing the liver and kidney, calming the liver, suppressing yang, managing qi and promoting blood circulation in water. Clinical tests prove that the total effective rate is as high as 97.5% and no evident adverse reaction is caused to the patients during treatment.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition, relate in particular to a kind of Chinese medicine preparation for the treatment of coronary heart disease with hypertension.
Background technology
Along with social development and living condition's improvement, the sickness rate of coronary heart disease is in rising trend, hypertension is the important risk factor of coronary heart disease, patient for coronary heart disease with hypertension, Comprehensive Treatment is preferred plan, and the medicine of therefore developing the Comprehensive Treatment primary disease that curative effect is high, side effect is little has important practical significance.Treatment with western coronary heart disease with hypertension is separately to treat two diseases at present, has the weak points such as incidence rate of a great variety, side effect increases, Long-term taking medicine expense is high, patient compliance is poor of taking medicine.The Chinese medicine compound of Chinese medicine possesses the advantage of multicomponent, many target spots, multipath treatment disease, side's multiple-effect, and convenient and safe, treating both the principal and secondary aspects of a disease, for clinical treatment coronary heart disease with hypertension provides a kind of new thinking.
Summary of the invention
The object of this invention is to provide a kind of Chinese medicine preparation for the treatment of coronary heart disease with hypertension.The coronary heart disease of modern medicine belongs to Chinese medicine thoracic obstruction category more, in long-term clinical practice, we observe the patient of coronary heart disease with hypertension, it is common pattern of syndrome that Chinese medical discrimination be take the resistance of hyperactivity of YANG due to deficiency of YIN, Yu Xue Bi, pathogenesis belongs to deficiency in origin and excess in superficiality, act on the principle of the traditional Chinese medical science " organic conception, determination for the treatment of based on pathogenesis obtained through differentiation of symptoms and signs ", treating different diseases with the same therapeutic principle, we have established the Therapeutic Principle of nourishing the liver and kidney, suppressing the hyperactive liver and subsiding YANG, vital energy regualting and blood circulation-promoting.
The object of the invention is to be achieved through the following technical solutions, the Chinese medicine preparation of this treatment coronary heart disease with hypertension is made by the Chinese medicine of following weight portion: Radix hemerocalis plicatae 9-15 part, Herba Caraganae intermediae 20-25 part, Cortex Ilicis Cornutae 25-30 part, Radix Tylophorae arenicolae 9-15 part, Rhizoma Nupharis Bornetii 30-60 part, Caulis Dalbergiae Hancei 6-9 part, Radix Pruni Japonicae 7-10 part, Radix Bauhiniae Lecomtei 9-15 part, Radix Amaranthi Caudati 10-30 part, Radix Buddlejae Butterflybush 14-16 part, Radix Campylotropis hirtellae 30-50 part, Caulis seu Radix Schisandrae Henryi 15-25 part.
Preferred: 12 parts of Radix hemerocalis plicataies, 23 parts of Herba Caraganae intermediaes, 28 parts of Cortex Ilicis Cornutaes, 12 parts of Radix Tylophorae arenicolaes, 45 parts of Rhizoma Nupharis Bornetiis, 7 parts of Caulis Dalbergiae Hanceis, 8.5 parts of Radix Pruni Japonicae, 12 parts of Radix Bauhiniae Lecomtei, 20 parts of Radix Amaranthi Caudatis, 15 parts of Radix Buddlejae Butterflybushs, 40 parts of Radix Campylotropis hirtellaes, 20 parts of Caulis seu Radix Schisandrae Henryi.
Preparation method: above-mentioned Chinese medicine decocting is made to decoction.
In side: Radix hemerocalis plicatae nourish blood suppressing the hyperactive liver, inducing diuresis to remove edema; Herba Caraganae intermediae nourishing the blood and yin; Cortex Ilicis Cornutae nourishing YIN, liver and kidney tonifying; Radix Tylophorae arenicolae enriching yin and nourishing kidney, invigorating the spleen and benefiting QI, spleen invigorating heart tonifying; Rhizoma Nupharis Bornetii nourishing YIN and clearing away heat; Caulis Dalbergiae Hancei promoting the circulation of QI to relieve pain; Radix Pruni Japonicae regulate the flow of vital energy dredge stagnant, removing food stagnancy poly-; Radix Bauhiniae Lecomtei regulating QI to relieve pain, diuretic reduces phlegm; Radix Amaranthi Caudati strengthening by means of tonics; Radix Buddlejae Butterflybush blood circulation promoting and blood stasis dispelling; Radix Campylotropis hirtellae promoting blood flow to regulate menstruation, regulating QI to relieve pain; Caulis seu Radix Schisandrae Henryi detumescence is nourished blood, regulating QI to expel dampness.
Clinical data
1. physical data is chosen 80 routine coronary heart disease with hypertension patients to our hospital in year January in January, 2008 to 2011 at random, male 51 examples wherein, female's 29 examples; 40～79 years old age; The course of disease is the longest 19 years, the shortest 5 months.Clinical all patient diagnosis inspections are all met to hypertension, diagnostic criteria for coronary heart disease.
2. diagnostic criteria diagnosis of coronary heart disease foundation WHO in 1980 is about diagnostic criteria for coronary heart disease.Diagnosing Hypertension is according to nineteen ninety WHO/ISH blood pressure level and defining classification.
3. this group of Therapeutic Method patient takes Chinese medicine preparation of the present invention, takes Radix hemerocalis plicatae 12g, Herba Caraganae intermediae 23g, Cortex Ilicis Cornutae 28g, Radix Tylophorae arenicolae 12g, Rhizoma Nupharis Bornetii 45g, Caulis Dalbergiae Hancei 7g, Radix Pruni Japonicae 8.5g, Radix Bauhiniae Lecomtei 12g, Radix Amaranthi Caudati 20g, Radix Buddlejae Butterflybush 15g, Radix Campylotropis hirtellae 40g, Caulis seu Radix Schisandrae Henryi 20g.Decocting is made decoction.Every day 2 times, each 200ml, 8 weeks was 1 course for the treatment of.If angina pectoris attacks during treatment, temporarily buccal nitroglycerin.Period in a medicine is advised patient's wine for giving off smoking, avoids pungent food, and diet is light, and smooth feelings will is untired.
4. criterion of therapeutical effect coronary heart disease and angina pectoris (thoracic obstruction) the standard of curative effect evaluation: draft according to the < < of Ministry of Health of the People's Republic of China new Chinese medicine guideline of clinical investigations > > in 1993.Effective: after carrying out the treatment of oral drugs, effectively reduce blood pressure to normal scope, coronary heart disease symptom obtains good improvement.Effective: can reduce blood pressure significantly, but not reach in normal range, more higher than normal arterial pressure scope, but relatively steadily can control, coronary heart disease symptom and sign are obviously improved.Invalid: blood pressure does not significantly reduce or raises gradually on the contrary, and it is more unstable that blood pressure detection obtains data, is difficult to control, and coronary heart disease symptom and sign have no remarkable alleviation, the performance that even carrying out property increases the weight of.
5. this group of therapeutic effect patient treatment observe the curative effect after the course for the treatment of, effective 58 examples (72.5%) wherein, effective 20 examples (25.0%), invalid 2 examples (2.5%), total effective rate 97.5%.During treatment, patient has no obvious adverse reaction.
The specific embodiment
Embodiment mono-: take Radix hemerocalis plicatae 12g, Herba Caraganae intermediae 23g, Cortex Ilicis Cornutae 28g, Radix Tylophorae arenicolae 12g, Rhizoma Nupharis Bornetii 45g, Caulis Dalbergiae Hancei 7g, Radix Pruni Japonicae 8.5g, Radix Bauhiniae Lecomtei 12g, Radix Amaranthi Caudati 20g, Radix Buddlejae Butterflybush 15g, Radix Campylotropis hirtellae 40g, Caulis seu Radix Schisandrae Henryi 20g.Above-mentioned Chinese medicine decocting is become to decoction.
Embodiment bis-: take Radix hemerocalis plicatae 15g, Herba Caraganae intermediae 25g, Cortex Ilicis Cornutae 25g, Radix Tylophorae arenicolae 9g, Rhizoma Nupharis Bornetii 60g, Caulis Dalbergiae Hancei 6g, Radix Pruni Japonicae 10g, Radix Bauhiniae Lecomtei 9g, Radix Amaranthi Caudati 30g, Radix Buddlejae Butterflybush 16g, Radix Campylotropis hirtellae 50g, Caulis seu Radix Schisandrae Henryi 15g.Above-mentioned Chinese medicine decocting is become to decoction.
Embodiment tri-: take Radix hemerocalis plicatae 9g, Herba Caraganae intermediae 20g, Cortex Ilicis Cornutae 30g, Radix Tylophorae arenicolae 15g, Rhizoma Nupharis Bornetii 30g, Caulis Dalbergiae Hancei 9g, Radix Pruni Japonicae 7g, Radix Bauhiniae Lecomtei 15g, Radix Amaranthi Caudati 10g, Radix Buddlejae Butterflybush 14g, Radix Campylotropis hirtellae 30g, Caulis seu Radix Schisandrae Henryi 25g.Above-mentioned Chinese medicine decocting is become to decoction.
Claims (2)
1. treat a Chinese medicine preparation for coronary heart disease with hypertension, it is characterized in that this Chinese medicine preparation made by the Chinese medicine of following weight portion: Radix hemerocalis plicatae 9-15 part, Herba Caraganae intermediae 20-25 part, Cortex Ilicis Cornutae 25-30 part, Radix Tylophorae arenicolae 9-15 part, Rhizoma Nupharis Bornetii 30-60 part, Caulis Dalbergiae Hancei 6-9 part, Radix Pruni Japonicae 7-10 part, Radix Bauhiniae Lecomtei 9-15 part, Radix Amaranthi Caudati 10-30 part, Radix Buddlejae Butterflybush 14-16 part, Radix Campylotropis hirtellae 30-50 part, Caulis seu Radix Schisandrae Henryi 15-25 part.
2. a kind of Chinese medicine preparation for the treatment of coronary heart disease with hypertension according to claim 1, is characterized in that this Chinese medicine preparation made by the Chinese medicine of following weight portion: 12 parts of Radix hemerocalis plicataies, 23 parts of Herba Caraganae intermediaes, 28 parts of Cortex Ilicis Cornutaes, 12 parts of Radix Tylophorae arenicolaes, 45 parts of Rhizoma Nupharis Bornetiis, 7 parts of Caulis Dalbergiae Hanceis, 8.5 parts of Radix Pruni Japonicae, 12 parts of Radix Bauhiniae Lecomtei, 20 parts of Radix Amaranthi Caudatis, 15 parts of Radix Buddlejae Butterflybushs, 40 parts of Radix Campylotropis hirtellaes, 20 parts of Caulis seu Radix Schisandrae Henryi.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310567272.5A CN103550480B (en) | 2013-11-15 | 2013-11-15 | Chinese herbal preparation for treating coronary heart disease complicated with hypertension |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310567272.5A CN103550480B (en) | 2013-11-15 | 2013-11-15 | Chinese herbal preparation for treating coronary heart disease complicated with hypertension |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103550480A true CN103550480A (en) | 2014-02-05 |
| CN103550480B CN103550480B (en) | 2015-06-03 |
Family
ID=50004952
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310567272.5A Expired - Fee Related CN103550480B (en) | 2013-11-15 | 2013-11-15 | Chinese herbal preparation for treating coronary heart disease complicated with hypertension |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103550480B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105998756A (en) * | 2016-07-26 | 2016-10-12 | 王晨 | Medicament for treating hypertension and coronary heart disease and preparation method of medicament |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1272379A (en) * | 1999-04-29 | 2000-11-08 | 李涛 | Medicine for treating coronary heart disease, arteriosclerosis and hypertension |
| CN1382463A (en) * | 2001-04-20 | 2002-12-04 | 徐忠廷 | Chinese-medicinal capsule for treating cardiovascular and cerebrovascular diseases |
| CN101468188A (en) * | 2007-12-27 | 2009-07-01 | 吴伶 | Health-care medicament for treating hypertension |
-
2013
- 2013-11-15 CN CN201310567272.5A patent/CN103550480B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1272379A (en) * | 1999-04-29 | 2000-11-08 | 李涛 | Medicine for treating coronary heart disease, arteriosclerosis and hypertension |
| CN1382463A (en) * | 2001-04-20 | 2002-12-04 | 徐忠廷 | Chinese-medicinal capsule for treating cardiovascular and cerebrovascular diseases |
| CN101468188A (en) * | 2007-12-27 | 2009-07-01 | 吴伶 | Health-care medicament for treating hypertension |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105998756A (en) * | 2016-07-26 | 2016-10-12 | 王晨 | Medicament for treating hypertension and coronary heart disease and preparation method of medicament |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103550480B (en) | 2015-06-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104491676A (en) | Goiter-treating stasis-removing soup | |
| CN102961613B (en) | Traditional Chinese medicine external lotion for treating pediatric chronic urticaria | |
| CN104825944A (en) | Drug for treating blood-heat psoriasis and preparation method thereof | |
| CN104547961B (en) | A kind of Chinese medicine composition for treating gall stone | |
| CN106138668A (en) | A kind of Chinese medicine composition treating COPD and preparation method thereof | |
| CN103550480B (en) | Chinese herbal preparation for treating coronary heart disease complicated with hypertension | |
| CN103157067A (en) | Traditional Chinese medicine preparation for treating trigeminal neuralgia | |
| CN103341146B (en) | Traditional Chinese medicine preparation for treating cold and dampness type chronic rhinitis | |
| CN105250968A (en) | Traditional Chinese medicine preparation for treating asthma | |
| CN103977216A (en) | Traditional Chinese medicinal preparation for treating irradiated brain stem type myeloen cephalospinal disease | |
| CN102836403B (en) | Chinese medicine for treating chronic nephritis by using root of low greenbrier | |
| CN102225119A (en) | Medicine for treating headache and preparation method thereof | |
| CN106389744A (en) | Formula of traditional Chinese medicine for treating gout | |
| CN105617162A (en) | Traditional Chinese medicine composition for treating aphthae | |
| CN104940459A (en) | Traditional Chinese medicine composition for treating distending pain of breasts during menstruation and preparation method thereof | |
| CN103301354B (en) | Preparation method of powder for treating infantile vaginitis | |
| CN104666824A (en) | Traditional Chinese medicinal composition for treating psoriasis | |
| CN104587168A (en) | Traditional Chinese medicinal composition for treating menorrhagia | |
| CN104435979B (en) | A kind of medicine for treating rheumatic lumbocrural pain pain | |
| CN104435133A (en) | Medicament for reducing fever | |
| CN103316258B (en) | Medicine composition for treating infantile vaginitis | |
| CN102716262B (en) | Traditional Chinese medicine formula for curing ankylosing spondylitis | |
| CN103908566A (en) | A traditional Chinese medicine medicament used for treating chronic atrophic gastritis and a preparing method thereof | |
| CN101085111B (en) | Acne-eliminating capsule | |
| CN110694034A (en) | Chinese patent medicine for treating cold and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150603 Termination date: 20151115 |
|
| EXPY | Termination of patent right or utility model |